Wendy’s Rejects $1.4 Billion Peltz Buyout Bid and Adopts Poison Pill Defense

DUBLIN, Ohio, Nov. 5 (TodayViralUSA) — Wendy’s rejected a $1.4 billion take-private offer from activist investor Nelson Peltz’s Trian Fund Management and partners, saying the bid undervalues the burger chain, and adopted a “poison pill” shareholder-rights plan to blunt a hostile takeover.

Trian’s group offered $7.35 a share in cash on Oct. 28, a premium of about 20% at the time. Partners included franchise operator Flynn Group and investment firms BlueFive Capital and Sixth Street Partners. A committee of independent Wendy’s directors called the proposal “substantially” below the company’s long-term value under a turnaround led by new Chief Executive Bob Wright.

Sales pressure and a poison pill

U.S. same-store sales fell 5.7% in the third quarter even as adjusted earnings of 13 cents a share beat estimates. Wright has made breakfast optional at U.S. stores to focus on lunch, dinner and late night, and the company signed a letter of intent to acquire up to 163 restaurants from Meritage Hospitality Group while shifting other Meritage markets through a bankruptcy-related process.

Trian and related parties own about 16.3% of Wendy’s. Trian president Peter May has sat on the board since 2008; Bradley Peltz, a son of Nelson Peltz, joined in 2025. Trian declined to comment after the rejection. Wendy’s shares were little changed near $7.75 in Thursday trading after the announcement.

Activists circle restaurants

Buyout interest in public restaurant chains has risen as traffic softens and costs stay high. Applebee’s parent Dine Brands recently adopted its own poison pill against a separate activist group. Wendy’s board said Wright’s early traffic improvements and menu resets justify staying public for now, even as Peltz argued the industry’s challenges favor a private reset.